Sonoma Pharmaceuticals, Inc.
SNOA
$2.79
$0.8040.20%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.75M | -3.69M | -4.56M | -4.84M | -5.08M |
| Total Depreciation and Amortization | 148.00K | 160.00K | 170.00K | 176.00K | 169.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 332.00K | 426.00K | 506.00K | 568.00K | 1.02M |
| Change in Net Operating Assets | 3.43M | 1.59M | 789.00K | 1.69M | -1.10M |
| Cash from Operations | 159.00K | -1.51M | -3.10M | -2.40M | -4.99M |
| Capital Expenditure | -30.00K | -29.00K | -5.00K | -17.00K | -210.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.00K | 15.00K | 15.00K | 15.00K | 108.00K |
| Cash from Investing | -15.00K | -14.00K | 10.00K | -2.00K | -102.00K |
| Total Debt Issued | 373.00K | 373.00K | 373.00K | 373.00K | 515.00K |
| Total Debt Repaid | -417.00K | -463.00K | -470.00K | -481.00K | -487.00K |
| Issuance of Common Stock | 3.45M | 4.10M | 2.53M | 1.78M | 4.31M |
| Repurchase of Common Stock | -1.00K | -1.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5.00K | 10.00K | 10.00K | 5.00K | 89.00K |
| Cash from Financing | 3.41M | 4.02M | 2.45M | 1.68M | 4.43M |
| Foreign Exchange rate Adjustments | -724.00K | -555.00K | -317.00K | 32.00K | 439.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.83M | 1.94M | -955.00K | -692.00K | -228.00K |
